On their quest to improve cancer immunotherapies, scientists strive to understand how a patient’s immune function changes through interactions with tumor cells. Chronic stimulation can render T cells exhausted and limit their capacity to respond to treatment. To characterize what drives this change and to identify early indicators of T cell exhaustion, researchers perform functional proteomics on patient immune cells over the course of treatment.
In this webinar brought to you by IsoPlexis, Abhishek Garg will highlight how he performed single cell multiomics to profile T cell states in several cancer types. He will discuss how these cells behaved following immunotherapy and how this information can guide immunotherapy design for resistant cancers
Topics to be covered
The range of T cell states across cancer types
Biomarkers for identifying precise clinical CD8+T cell states
Guiding clinical application and tailoring immunotherapy to patient immune function
Thursday, April 21, 2022
11:00 AM - 12:00 PM Eastern Time (5 - 6 PM CET)
This webinar will also be available on-demand.
Meet the speaker
Abhishek D. Garg, PhD Assistant Professor Head, Laboratory of Cell Stress and Immunity Department of Cellular and Molecular Medicine Katholieke Universiteit Leuven ( KU Leuven )
Sponsored by
Register
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
